Kolexia
Clement Laurence Hématologie
Clement Laurence
Hématologie
Hôpital Haut-lévêque
Pessac, France
76 Activités
0 Followers
Scientifique
Digital
Production scientifique
Activités par an
Expertise
Sujets de recherche
{{person.topmesh1.name}} Leucémie aigüe myéloïde Leucémies Maladie du greffon contre l'hôte Leucémie myéloïde Anémie Anémie aplasique Lymphomes Maladie de Hodgkin Maladie aigüe

Collaborateurs

Voir plus
Michallet Mauricette
Michallet Mauricette
Centre Léon-Bérard, Lyon, France
Yakoub-Agha Ibrahim
Yakoub-Agha Ibrahim
Centre Hospitalier de Lille, Lille, France
Chevallier Patrice
Chevallier Patrice
Hôpital Hôtel-Dieu Nantes, Nantes, France
Mohty Mohamad
Mohty Mohamad
Hôpital Saint-Antoine, Paris, France

Industries

Voir plus
Jazz Pharmaceuticals
1 collaboration(s)
Dernière en 2020
{{person.topindus2.name}}
{{person.topindus2.tot}} collaboration(s)
Dernière en {{person.topindus2.last}}
{{person.topindus3.name}}
{{person.topindus3.tot}} collaboration(s)
Dernière en {{person.topindus3.last}}
{{person.topindus4.name}}
{{person.topindus4.tot}} collaboration(s)
Dernière en {{person.topindus4.last}}

Dernières activités

Voir plus
On behalf of the SFGM-TC: Real-life use of third-party virus-specific T-cell transfer in immunocompromised transplanted patients.
HemaSphere   27 janvier 2024
Reduced-toxicity myeloablative conditioning regimen using fludarabine and full doses of intravenous busulfan in pediatric patients not eligible for standard myeloablative conditioning regimens: Results of a multicenter prospective phase 2 trial.
Bone marrow transplantation   26 août 2022
Adoptive immunotherapy with antiviral CTL infusion: French clinical and virological safety survey
Abstracts of the Annual Meeting of French Society of Pharmacology and Therapeutics, 14–16 June 2022, Lille, France   05 juin 2022
VANDA regimen followed by blinatumomab leads to favourable outcome in patients with Philadelphia chromosome-negative B-precursor acute lymphoblastic leukaemia in first relapse.
British journal of haematology   07 mai 2022
Eltrombopag Added to Immunosuppression in Severe Aplastic Anemia.
The New England journal of medicine   19 janvier 2022
AMAHRELIS : ADCETRIS MAINTENANCE AFTER AUTOLOGOUS STEM CELL TRANSPLANTATION IN HODGKIN LYMPHOMA : A REAL LIFE STUDY FROM SFGMTC AND LYSA GROUPS
16th International Conference on Malignant Lymphoma, Virtual Edition, 18–22 June, 2021   17 juin 2021
189 | AMAHRELIS : Adcetris maintenance after autologous stem cell transplantation in Hodgkin lymphoma : a real life study from SFGMTC and LYSA groups
16th International Conference on Malignant Lymphoma, Virtual Edition, 18–22 June, 2021   09 juin 2021
Role of an academic network in the use and survey of an advanced therapy medicinal product under hospital exemption for adoptive immunotherapy of refractory viral infections
Abstracts of the Annual Meeting of French Society of Pharmacology and Therapeutics, 15–16 June 2021, E‐meeting, France   02 juin 2021
Prospective Multicenter Study of A Reduced-Toxicity Myeloablative Conditionning Regimen Using Fludarabine And Full Doses of Iv Busulfan in Pediatric Patients Not Eligible For Myeloablative Regimens
Abstracts from the 47th Annual Meeting of the European Society for Blood and Marrow Transplantation (EBMT)   01 juin 2021
RACE: A Prospective Randomized Multicenter Study Comparing Horse Antithymocyte Globuline (hATG) + Cyclosporine A (CsA) With or Without Eltrombopag as Front-line Therapy for Severe Aplastic Anemia Patients.
Essai Clinique (Novartis)   21 décembre 2020